ERS Publications Podcasts

ERS Monograph: Bronchiectasis

ERS Publications Podcasts

Show Notes

"Patient voice should not be something we add at the end of the process. We should acutally shape the entire process, from the beginning, with the patient."

Key leaders of EMBARC (the European Multicentre Audit and Research Collaboration) Amelia Shoemark and Stefano Aliberti join Guido Marchi in a podcast focusing on the latest ERS Monograph: Bronchiectasis. Guido, who is the Early Career Member representative for the Monograph, asks Stefano and Amelia about the foundation of EMBARC and its increasing international reach, better integration of the patient voice, the impact of the 2025 European Respiratory Society (ERS) bronchiectasis guidelines, and the turning point in treatment that dipeptidyl peptidase-1 (DPP-1) offers.

More from ERS Publications Podcasts

Oct 20, 2026

"We [should] not only focus on one treatment option but we should discuss how we can combine different options; this has to be studied in more detail"

Sep 25, 2026

As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews editorial board member Christina Thornton and associate editor Marcus Mall about their Back to Basics review article on bridging the airway microbiome and targeted therapy in bronchiectasis, published in this issue of the ERJ (https://doi.org/10.1183/13993003.00239-2026).

Aug 28, 2026

As part of the August issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Marlies van Dijk (University of Groningen, Groningen, The Netherlands) about her multicentre randomised crossover trial of fentanyl and morphine for persistent dyspnoea in COPD, published in this issue of the ERJ (https://doi.org/10.1183/13993003.01431-2025).

Aug 12, 2026

As part of the July issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Marlies Wijsenbeek about data from the whole follow-up period of the FIBRONEER-ILD trial of nerandomilast in progressive pulmonary fibrosis, published in this issue of the ERJ (https://doi.org/10.1183/13993003.01272-2025).

Aug 10, 2026

"Making ultrasound as widespread and as used as the stethoscope... that's the big challenge going forwards"

See all episodes →